Advertisements

Bifluorid 12

Quick links to important sections

Bifluorid 12

Advertisements
Advertisements

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Bifluorid 12

Quick Facts

Property Description
Active Ingredients Sodium Fluoride, Calcium Fluoride
Form Paint-On Varnish (Suspension)
Pharmacological Class Cariostatic Agent, Desensitizing Agent
Origin Synthetic Combination Product

What Type of Medicine is Bifluorid 12?

Bifluorid 12 is a synthetic pharmaceutical preparation classified within the pharmacological class as a cariostatic agent and desensitizing agent, used for high-concentration topical fluoride treatment in dental procedures. The drug is delivered in the specialized dosage form of a paint-on suspension or varnish with a liquid consistency, designed for precise application directly onto the tooth surface. Topical fluoride products contribute to dental protection against decay. Unlike standard fluoride gels, the varnish formulation adheres strongly to the enamel, a feature clinically recognized for extending the contact time between the active ingredients and the dental surface.


Composition: Dual-Source Fluoride and Origin

The preparation is a combination product that contains two distinct active ingredients: Sodium Fluoride and Calcium Fluoride, which together supply the necessary Fluoride ions. This synthetic formulation is held within a clear, thin synthetic resin matrix that ensures the active components adhere tightly to the dental hard tissue. This formulation is distinguished by its dual protection mechanism: Sodium Fluoride offers immediate fluoride release, while Calcium Fluoride acts as a slower-dissolving fluoride reservoir for sustained protection. Dual-source fluoride varnishes support the process of remineralization.


General Purpose: Protection and Sensitivity Relief

The overall general purpose of the Bifluorid 12 preparation is to support the preservation of tooth integrity and provide relief from nerve-related discomfort. As a cariostatic agent, its primary function is to chemically strengthen the tooth by promoting the remineralisation promotion of the enamel, making the tooth structure resistant to acid dissolution. Additionally, the formula serves as a highly effective desensitizing agent by physically assisting in the sealing of dentinal tubules, which are micro-channels responsible for transmitting external stimuli like cold or touch.

Advertisements

What side effects are possible with Bifluorid 12?

Possible side effects and safety information

The officially documented adverse effects for this topical fluoride varnish preparation are classified primarily by their frequency and the body system affected, based on regulatory reports.

Frequency-Classified Adverse Reactions

Adverse effects are broadly categorized by the likelihood of occurrence:

  • Common Reactions: The most frequently documented reactions are localized and transient, primarily involving the General Disorders and Administration Site Conditions system-organ class. These include temporary oral discomfort, such as a short-lived burning or stinging sensation, and local irritation of the oral mucosa, like stomatitis or gingival swelling.
  • Rare to Very Rare Reactions: Systemic adverse reactions are classified as rare (or very rare, extless 1/10,000). The Gastrointestinal Disorders class includes nausea and vomiting, often associated with accidental ingestion. The Immune System Disorders class includes the possibility of severe hypersensitivity reactions.

Systemic and Serious Safety Information

While extremely rare, regulatory documents acknowledge the potential for serious adverse reactions, including anaphylactic reaction and angioedema (rapid, potentially dangerous swelling). These are serious manifestations of systemic hypersensitivity and require immediate recognition.

Official labeling defines specific safety restrictions and contraindications. The preparation is not intended for use in individuals with confirmed hypersensitivity to any of its components or in patients presenting with severe oral mucosal conditions, such as ulcerative stomatitis or desquamative gingivitis. Furthermore, a history of uncontrolled bronchial asthma may be a relevant contraindication due to the rare risk of dyspnea. Regulatory guidance also states that other high-dose fluoride preparations should not be administered on the same day as the varnish application.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose following the ingestion of high-concentration fluoride varnish (Bifluorid 12) is primarily an acute toxicity event related to the fluoride ion content. Regulatory sources identify the Probable Toxic Dose (PTD) threshold for ingestion at approximately 5 mg fluoride per kg of body weight.

Accidental ingestion may lead to acute, rapidly occurring manifestations in the gastrointestinal system, including severe nausea, intense vomiting, diarrhea, abdominal pain, and increased salivation. In severe cases, hematemesis (vomiting blood) is a documented sign of systemic toxicity.


Severe Manifestations and Emergency Action

Severe overdose can result in life-threatening metabolic and systemic complications, such as profound hypocalcemia (low blood calcium) and hypokalemia, which may trigger muscular weakness, tremors, and spasms. These effects can escalate to serious cardiovascular compromise, including an irregular heartbeat and, potentially, cardiac arrest.

Immediate medical assistance is mandated for any suspected ingestion. Regulatory guidance requires immediate hospitalization if the estimated dose is greater than the 5 mg F/ kg threshold. Treatment is symptomatic and supportive, often beginning with the oral administration of calcium-containing substances like milk to bind the fluoride and mitigate gastrointestinal effects. Continuous hospital monitoring of vital and metabolic signs is required due to the severity of potential complications. Specialized attention is necessary for children, as doses of mathbf16 mg F/ kg have been reported as fatal in this population.

Advertisements

Therapeutic Uses of Bifluorid 12

What Bifluorid 12 Treats: Main Uses and Benefits

Bifluorid 12 plays a role in managing symptomatic discomfort and is relevant for easing symptoms related to chronic tooth weakness. It is used exclusively in a clinical setting to address specific symptomatic and protective needs. The therapeutic scope generally includes the management of dentin hypersensitivity, assistance with post-operative discomfort, and utilization in caries prophylaxis.


Relief of Transient Tooth Sensitivity

This preparation is commonly applied to manage dentin hypersensitivity, which manifests as sharp, short-lived pain triggered by common external stimuli like exposure to cold or sweet foods. Its application is relevant for easing the symptoms related to physical discomfort, helping patients cope more steadily with these distressing symptomatic manifestations, and contributes to easing the overall symptom load during periods of heightened symptoms. This is particularly relevant when gum recession has exposed sensitive root surfaces.

“The application helps maintain a sense of stability when symptoms are more noticeable.”

Intensive Prevention and Post-Procedural Support

This preparation is considered relevant as a supportive measure in caries prophylaxis, and is relevant for managing symptoms related to inflammatory or irritative states. It is applied across therapeutic domains involving chronic tooth structure weakness, which may assist with managing the risk of future decay, such as at the margins of existing restorations. Furthermore, the varnish is often used in clinical scenarios to assist with symptomatic relief following various dental procedures, including professional tooth cleaning and scaling, providing temporary assistance in symptom stabilization and may assist with managing symptoms that interfere with daily functioning.

Quick Fact: Relief for Acute Sensitivity
Primary Therapeutic Goal Symptom management for dentin hypersensitivity and caries prevention.
Symptom Profile Addressed Transient, stimulus-induced tooth pain and chronic tooth weakness.
Typical Context of Use Following professional hygiene procedures or in areas of gum recession.

Regulatory References

  1. U.S. Food and Drug Administration (FDA) Device Indications for Fluoride Varnish
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Bifluorid 12?

The eligibility profile for using Bifluorid 12, a high-concentration topical fluoride varnish, is defined by regulatory standards that establish who may receive the professional treatment and who must be excluded.


Populations Allowed and Restricted

Bifluorid 12 is generally permitted for use in adults, older adults, and the pediatric population (children and adolescents) for topical application in caries prevention and desensitization. The primary restrictions relate to specific contraindications and conditional use requirements.

Classification Population Group or Condition
Absolute Contraindication Hypersensitivity to any component (including fluoride or excipients)
Absolute Contraindication Active ulcerative gingivitis or stomatitis
Absolute Contraindication Patients with bronchial asthma
Use Not Recommended Pregnant women or lactating women (due to insufficient safety data)

Eligibility-Related Requirements

Individuals who use other high-dose fluoride preparations (such as gels or supplements) must suspend their use on the day of and for several days following the Bifluorid 12 application. No specific contraindications are typically specified in official labeling for patients with hepatic or renal impairment, as systemic exposure from the topical varnish is minimal.

Advertisements

What should I know about interactions with other medicines?

Interactions Resulting in Additive Exposure or Reduced Absorption

The regulatory profile for this topical preparation defines constraints based on potential additive systemic exposure and reduced absorption. A pharmacodynamic restriction requires the temporary interruption of other fluoride sources, such as oral rinses or tablets, for a period following treatment to mitigate the risk of cumulative systemic exposure. Co-administration with other high-concentration topical fluoride preparations, including gels or foams, is similarly restricted on the same day.

Timing Constraints and Chemical Interference

A pharmacokinetic interference is documented with agents that chemically bind fluoride. The systemic absorption of the fluoride component may be reduced by co-administration with calcium-containing products, including supplements and dairy food, and with aluminum hydroxide-containing products. To manage this effect, official guidelines mandate a minimum separation of at least two hours between the oral ingestion of the fluoride component and these chelating agents. Furthermore, specific administration constraints exist to maintain the physical integrity of the varnish coating: the consumption of hot drinks and alcohol-containing products must be avoided for approximately four hours post-application.

Advertisements

Mechanism of Action

The mechanism of action is local and defined by two complementary pharmacodynamic domains: chemical interaction with tooth mineral and physical barrier formation.

Modulating Mineral Crystal Structure

This domain covers the primary chemical targets: the hydroxyapatite crystals of enamel and dentine. The release of highly reactive Fluoride ions ( F^-) facilitates an ionic exchange, replacing hydroxyl ( OH^-) groups to form the less acid-soluble Fluorapatite. This structural modulation of the mineral lattice lowers the critical pH for dissolution, resulting in decreased acid solubility of the mineral phase.

Interrupting Hydrodynamic Signal Transmission

This mechanism involves a physical interaction with exposed dentinal tubules, the microscopic channels that facilitate fluid movement between the dentine surface and the pulp. The rapid co-precipitation of calcium and fluoride ions creates minute Calcium Fluoride ( CaF2) crystallites that physically plug the tubule orifices. This physical occlusion stops the rapid fluid movement within the tubules, thereby inhibiting the activation of mechanoreceptors and resulting in modulation of hydrodynamic signal transmission.

Suppressing Microbial Metabolic Pathways

This domain targets the enzymatic systems of cariogenic bacteria. Under the acidic conditions of a biofilm, F^- ions enter the bacteria as Hydrogen Fluoride ( HF), where they suppress key glycolytic enzymes, such as enolase, and the H^+-ATPase pump. This enzymatic inhibition impairs the bacteria's ability to metabolize sugars and excrete acid, resulting in a decrease in the concentration of metabolic acid produced in the localized biofilm environment.

Advertisements

Dosage and Administration Information

How to Use Bifluorid 12

The administration of Bifluorid 12, a high-concentration topical fluoride preparation, is structured as an intermittent, professional procedure. The use is defined by specific procedural domains rather than daily patient regimens.


Administration Scope

Feature Administration Principle
Route of Administration Topical application, meaning it is applied directly and only to the tooth surfaces.
Dosing Schedule The application typically involves a thin, uniform film coating the target enamel or dentin. Dose is procedural, not based on weight or volume.
Frequency For general caries prophylaxis, application is typically performed every three to six months, depending on individual risk assessment.
Repetitive Use For specific applications, such as managing dentin hypersensitivity, treatment may involve repeated use in short, defined intervals, such as two to three applications at a seven-day interval.

Procedural Administration Conditions

Bifluorid 12 is designated for professional use only and must be applied by a trained dental or medical professional in a clinical setting. Adherence to preparation steps is relevant for proper use:

  • Surface Preparation: The application site is cleaned and thoroughly dried with air or gauze prior to the application of the varnish to promote adhesion.
  • Post-Application Care: Following treatment, standard procedural care includes avoiding brushing or flossing the treated areas for a period of at least 4 to 24 hours. This time constraint is intended to ensure the adherent varnish remains in place to facilitate prolonged contact with the tooth surface and optimize fluoride delivery. The product is used across all age groups, including pediatric patients, when applied sparingly.
Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Mechanism of Action Studies

Preclinical research suggests the compound, containing sodium fluoride (NaF) and calcium fluoride (CaF), is thought to influence inflammation and pain signal pathways. Initial in vitro studies examined whether the compound influenced specific inflammatory markers. The mechanism is believed to involve the formation of calcium fluoride precipitates that help to seal exposed dentinal tubules, reducing the fluid movement thought to cause sensitivity.

  • Preclinical Research: Research detailed the evaluation of changes in cytokine production and tissue edema in animal models of induced arthritis. Other studies focused on the product's ability to occlude dentinal tubules, a key factor in managing hypersensitivity.

Efficacy and Symptom Management

Research has investigated the measurement of pain and swelling in affected joints following administration. Studies have explored the measurement of changes in joint function, typically focusing on conditions like dentin hypersensitivity where the product is often utilized.

  • Pain Reduction: Randomized clinical trials (RCTs) evaluated pain intensity using scales such as the Visual Analog Scale (VAS). One split-mouth RCT found that the application of a similar fluoride varnish was associated with a statistically significant reduction in VAS-measured pain intensity over a six-month follow-up period.
  • Duration of Effect: Longitudinal studies have examined whether the observed pain reduction effects persist over time. Findings from an 8-week RCT reported sustained pain reduction with bifluoride-containing varnish, noting its effect increased at the 4- and 8-week follow-up periods compared to baseline.

Tolerability and Subpopulations

Clinical trials have focused on evaluating the frequency and severity of adverse events in adult populations. The primary adverse events reported across completed dental trials have generally been minor and localized.

  • Safety Profile: Studies often compare the incidence of adverse events with a placebo or a different treatment (e.g., bonding resin). Trials typically report the absence of Grade 3 or higher serious adverse events attributed to the product in the evaluated populations.
  • Specific Considerations: Studies have explored the compatibility of the varnish with other dental procedures, such as the bond strength of certain resin cements to dentin after application.

Key Studies & References

  1. Treating cervical dentin hypersensitivity with fluoride varnish (A 24-week randomized clinical trial)
  2. Desensitizing treatments for dentin hypersensitivity: a randomized, split-mouth clinical trial (Assessing various agents including fluoride varnishes)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Bifluorid 12 (FAQ)


Q: How quickly can someone expect to see a result from Bifluorid 12?

A: Studies and official product information indicate that the desensitizing effects, which rely on the physical sealing of the microscopic dentinal tubules, are typically noticed shortly after application once the varnish has hardened. The broader protective effect for remineralization is sustained over several months, with clinical studies examining outcomes and persistence over follow-up periods.


Q: Does Bifluorid 12 interact with common medications like ibuprofen?

A: Regulatory information indicates no known interactions between this topical dental preparation and general systemic medications, such as over-the-counter pain relievers. The interactions noted in official documents are primarily with products that bind calcium or aluminum, or with other high-concentration fluoride sources.


Q: Can people with certain allergies still use Bifluorid 12?

A: Official labeling contraindicates the use of Bifluorid 12 in individuals who have a confirmed hypersensitivity or allergy to any component of the varnish. Official safety constraints require informing the professional of all known allergies, including hypersensitivity to inactive ingredients such as certain resins (e.g., colophony), which may be present in the formulation.


Q: Is there a known risk of interacting with herbal supplements?

A: Official regulatory guidance states the importance of informing the professional about all products being used, including herbal supplements. For this topical product, the primary risk of interaction involves oral products that can chelate or bind active ingredients, such as those containing calcium or aluminum, not general herbal supplements.


Q: Can people with a history of kidney issues use Bifluorid 12?

A: Because this is a high-concentration topical preparation, systemic exposure is generally anticipated to be minimal. Official documents typically do not list severe kidney or liver impairment as a contraindication for using this specific topical formulation.


Q: Are there any specific safety considerations for people with asthma?

A: Official documents list uncontrolled bronchial asthma as a specific contraindication for the use of Bifluorid 12. This restriction is noted due to the rare risk of adverse respiratory effects, such as breathing difficulty (dyspnea), that may occur following application.


Q: Can Bifluorid 12 be applied if a patient has gum inflammation?

A: The varnish is strictly contraindicated for use in patients presenting with severe, acute oral mucosal conditions, specifically named as ulcerative stomatitis or desquamative gingivitis. The application of the varnish in cases of minor, localized gum inflammation is not addressed as a specific absolute contraindication and would be determined by the treating professional.


Q: What official documents describe the intended application frequency?

A: The professional application frequency is described in guidelines published by regulatory and public health authorities, which define its use as an intermittent, professional procedure. These guidelines often recommend application every three to six months for general caries prophylaxis.


Q: Are there any known foods or drinks that should be avoided right after use?

A: Official post-application instructions define constraints requiring the avoidance of hot drinks, alcohol-containing products, and sticky or crunchy foods for a specified period (e.g., 4 to 24 hours). This time frame is necessary to protect the varnish layer, allowing it to remain on the tooth surface for the optimal delivery of the active ingredients.


Q: Are there any warnings about using Bifluorid 12 with other fluoride treatments?

A: Yes. Regulatory documentation notes a constraint on the temporary interruption of other high-concentration topical or systemic fluoride sources (like rinses or tablets) around the time of treatment. This measure is in place to mitigate the risk of cumulative systemic fluoride exposure.


Q: Why is professional application often required for Bifluorid 12?

A: Professional application is required because Bifluorid 12 contains a high concentration of active fluoride and is classified for prescription or professional-use only. This requirement helps ensure the correct, precise dosage is applied only to the intended tooth surfaces, thereby minimizing the potential risk of accidental ingestion and systemic exposure.


Q: How does the concentration of fluoride in Bifluorid 12 compare to toothpaste?

A: Bifluorid 12 is defined in official documents as a high-concentration topical fluoride treatment used in clinical settings. The concentration of the active ingredient is significantly higher than the concentration typically found in standard, over-the-counter fluoride toothpaste.


Q: What specific conditions or diseases make someone ineligible for Bifluorid 12?

A: Official regulatory documents define ineligibility based on specific absolute contraindications. These conditions include a confirmed hypersensitivity to any component, active ulcerative gingivitis or stomatitis, and a history of uncontrolled bronchial asthma.


Q: Can Bifluorid 12 be used on all tooth surfaces?

A: The product is applied as a thin, uniform film coating on the target tooth surfaces, which include the enamel and exposed dentin, as determined by the dental professional. Its use is localized and focused on the areas requiring treatment or prophylaxis.


Q: Is it normal to feel a temporary change in taste after application?

A: Local and transient temporary oral discomfort, which can include a short-lived burning or stinging sensation, is documented in the common adverse reactions reported for this preparation. This general discomfort may also be perceived by some patients as a temporary change in taste.

Advertisements

How should Bifluorid 12 be stored and disposed of?

Storage and Disposal Requirements

All storage and disposal procedures for Bifluorid 12 must strictly adhere to the mandatory requirements stated in official regulatory labeling.

Storage Conditions

The preparation must be stored at controlled room temperature, typically 15^circmathrmC to 30^circmathrmC (59^circmathrmF to 86^circmathrmF). The product must be protected from heat and it is strictly required to not freeze the contents. To maintain stability, the varnish must be kept in the original container, which should remain tightly closed to prevent exposure to air and moisture.

Safety and Disposal

The product must be stored out of the sight and reach of children as documented in the official labeling. Disposal of any unused or expired product, including the container, must be carried out in accordance with all local, state, and federal regulations. Due to environmental restrictions, the product must not be disposed of into the sanitary sewer or wastewater system.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bifluorid 12 found in:

A-Z Index: